JudithFeinbergMD

Infectious Disease • Cincinnati, OH

Professor of Medicine Associate Chair of Medicine for Faculty Development

Join to view full profile

Dr. Feinberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Feinberg's full profile

Already have an account?

Office
222 Piedmont Ave
Ste 6000
Cincinnati, OH 45219
Phone+1 513-475-8522

Fax+1 513-475-7327

Education & Training

Ronald Reagan UCLA Medical Center1984
Rush University Medical CenterResidency, Internal Medicine, 1979 - 1982
Rush University Medical CenterInternship, Internal Medicine, 1979 - 1980
Rush Medical CollegeMD, Medicine, 1975 - 1979
Rush Medical College of Rush University Medical CenterClass of 1979
University of ChicagoBA, Russian Civilization, 1963 - 1967

Certifications & Licensure

CA State Medical License 1982 - Present
NJ State Medical License 1985 - Present
NY State Medical License 1985 - Present
OH State Medical License 1995 - 2027
WV State Medical License 2016 - 2026
MD State Medical License 1987 - 1996
IL State Medical License 1980 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
Completed
Phase 3
An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies
Completed
Phase 3
A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia
Completed
Phase 3
Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
Completed
Phase 3
The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC
Completed
Phase 1
A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies
Completed
Phase 3
A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients
Completed
Phase 3
A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia
Completed
Not Applicable
A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)
Completed
Not Applicable
Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy
Withdrawn
Phase 2
Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation Start of enrollment: 2006 Mar 31
Completed
Phase 1, Phase 2
FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir Start of enrollment: 2013 Apr 25
Completed
Phase 4
Nasal Naloxone for Narcotic Overdose Start of enrollment: 2013 Sep 01
Unknown status
Phase 4
Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) Start of enrollment: 2014 Jan 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

266 citations
A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquire...
W D Hardy, Judith Feinberg, Dianne M. Finkelstein, M E Power, Weili He
The New England Journal of Medicine. 1992-12-24
34 citations
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis.
Richard A Jenkins, Bridget M Whitney, Robin M Nance, Todd M Allen, Hannah L F Cooper
Addiction Science & Clinical Practice. 2022-07-26
2050 citations
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or...
Scott M. Hammer, Kathleen Squires, Michael Hughes, Janet M. Grimes, Lisa M. Demeter
The New England Journal of Medicine. 1997-09-11

Press Mentions

State Senate Ignores Science, Experts, ResearchMarch 21st, 2021
Facts Rebuke Tarr’s Take on Harm ReductionFebruary 27th, 2021
Quick Look: Harm Reduction History in Greater CincinnatiFebruary 18th, 2021
Join now to see all

JudithFeinbergMD

Dr. Feinberg is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.